Home
Who we are
Pipeline
News
Contact
Our mission is to develop essential medicines to improve
care and support of pediatric orphan diseases.
ORPHELIA Pharma
is a biopharmaceutical company dedicated to the development and marketing of pediatric drugs in oncology and neurology.
Latest news and reports
Latest news and report
16 octobre 2019
ORPHELIA at the annual SIOP Congress
Read more
15 octobre 2019
Dr. Caroline Lemarchand appointed Chief Pharmaceutical Development Officer
Read more
30 septembre 2019
CHMP has adopted a positive opinion for Ivozall®
Read more
9 septembre 2019
ORPHELIA at the XIIth National Oncology Days of the French Society of Pharmacy Oncology
Read more
3 septembre 2019
Orphan Drug Designation granted for temozolomide in the treatment of neuroblastoma
Read more
28 août 2019
ORPHELIA at the 22nd French Epilepsy Days
Read more
22 août 2019
ORPHELIA recrute un Responsable Affaires Règlementaires
Read more
20 juin 2019
ORPHELIA recrute un Pharmacien Responsable
Read more
